Skip to main content
. 2021 Dec 1;11(12):1600. doi: 10.3390/brainsci11121600

Table 1.

Demographic and clinical characteristics of the study sample.

Demographics LPA
(n = 12)
SD
(n = 11)
PNFA
(n = 9)
AD
(n = 19)
bvFTD
(n = 26)
Control
(n = 31)
F-Test Post Hoc
Age (y) 69.8 (7.0) 63.8 (6.2) 67.1 (6.1) 66.1 (7.6) 64.8 (5.8) 65.4 (6.3) NS -
Education (y) 11.9 (3.5) 13.8 (2.3) 12.4 (3.2) 13.2 (3.7) 12.1 (3.7) 13.9 (3.7) NS -
Sex (M:F) 7:5 7:4 2:7 10:9 19:7 16:15 NS -
Disease Duration (y) 5.2 (2.5) 6.7 (2.9) 6.1 (3.0) 7.2 (5.1) 7.5 (4.7) - NS -
ACE-III Total (100) 63.7 (17.1) 71.1 (21.7) 80.0 (16.1) 69.6 (12.5) 82.8 (9.3) 94.1 (3.8) *** CN > Patients
FRS (Rasch score) 0.85 (1.4) 0.82 (1.4) 2.7 (1.8) 0.42 (1.1) −0.38 (1.3) - *** PNFA > AD, bvFTD
ZBI (48) 13.2 (6.8) 18.7 (8.7) 11.4 (6.5) 15.2 (8.7) 21.4 (10.0) - * bvFTD > PNFA

Notes: Means with standard deviations in parentheses. AD = Alzheimer’s disease; bvFTD = behavioural variant of frontotemporal dementia; CN = controls; LPA = logopenic progressive aphasia; PNFA = progressive non-fluent aphasia; (y) = years; ZBI = Zarit Burden Interview. * p < 0.05; *** p < 0.0001; - = not applicable; NS = not significant. Education data available for 28 controls. Disease duration available for 15 AD. ACE-III data available for 29 controls. FRS data available for 14 AD and 20 bvFTD.